The World’s Largest International Breast Cancer Conference – ESMO 2025 – Was Successfully Held in Munich

Bilguunzaya Batmunkh
May 17
2 min read

One of the Most Prominent Global Health Events of 2025 – The Breast Cancer Subspecialty Congress of the European Society for Medical Oncology (ESMO) – Was Successfully Held in Early May in Munich, Germany

This major event brought together over 4,000 cancer researchers, physicians, and experts from 103 countries, serving as a key platform to present and discuss the latest trends and advancements in breast cancer diagnosis, treatment, follow-up, prevention, innovation, and research.

Main Topics Discussed:

During the congress, the following core areas were highlighted and discussed:

Early-Stage Breast Cancer Diagnosis and Treatment: The importance of genetic testing, biomarkers, and molecular-level diagnostics, along with new effective diagnostic tools.
Management of Metastatic Breast Cancer: Targeted therapies and immunotherapies for patients with metastases, and strategies to overcome drug resistance.
Advancements in Hormonal Therapy: Methods to enhance outcomes in hormone receptor-positive breast cancer, including clinical studies of CDK4/6 inhibitors.
Radiation and Surgical Approaches: Breast-conserving surgery, advances in radiotherapy, and planning aimed at preserving patients’ quality of life.
Post-Treatment Monitoring and Recurrence Prevention: Strategies to maintain quality of life, psychological support, patient monitoring, and improved follow-up systems.
Adverse Effects and Drug Reaction Management: Early detection and effective management of treatment-related side effects.

Participation from Mongolia:

Representatives from the following Mongolian institutions actively participated in the congress with the aim of introducing the latest research insights into the country’s oncology practice:

Intermed Hospital
First Central Hospital of Mongolia
Rehamed Hospital

The participating oncologists engaged with new treatment methods, reviewed recent clinical trial results, and exchanged experiences with leading global physicians and researchers—an effort that holds significant value for advancing cancer care in Mongolia.

Conclusion:

This ESMO congress not only showcased the global scientific and clinical advancements in breast cancer care but also served as a vital platform for professional exchange, collaboration, and setting future research directions.